Citation Impact
Citing Papers
SNARE Proteins: One to Fuse and Three to Keep the Nascent Fusion Pore Open
2012 StandoutScienceNobel
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Structure of the human TRPM4 ion channel in a lipid nanodisc
2017 StandoutScienceNobel
Novel Controlled-Release Lemna -Derived IFN- α 2b (Locteron): Pharmacokinetics, Pharmacodynamics, and Tolerability in a Phase I Clinical Trial
2008
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Hepatocellular carcinoma
2003 Standout
ATP-binding cassette transporter A1 (ABCA1) affects total body sterol metabolism
2001
Effects of the Antifungal Agents on Oxidative Drug Metabolism
2000
Multifunctional Lipid/Quantum Dot Hybrid Nanocontainers for Controlled Targeting of Live Cells
2006 StandoutNobel
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Unravelling hepatitis C virus replication from genome to function
2005 StandoutNatureNobel
Has the era of individualised medicine arrived for antifungals? A review of antifungal pharmacogenomics
2011
Hepatitis C virus induces interferon-λ and interferon-stimulated genes in primary liver cultures
2010 StandoutNobel
Cytochrome P-450 Polymorphisms and Response to Clopidogrel
2008 Standout
Unconventional miR-122 binding stabilizes the HCV genome by forming a trimolecular RNA structure
2013 StandoutNobel
Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
2002
Clinical Relevance of the Pharmacokinetic Interactions of Azole Antifungal Drugs with Other Coadministered Agents
2009
Mitochondrial Dysfunction in C. elegans Activates Mitochondrial Relocalization and Nuclear Hormone Receptor-Dependent Detoxification Genes
2019 StandoutNobel
Identification and Characterization of the Binding Sites of P-Glycoprotein for Multidrug Resistance-Related Drugs and Modulators
2004
Nanotechnology: A Focus on Nanoparticles as a Drug Delivery System
2006
Delayed Induction, Not Impaired Recruitment, of Specific CD8+ T Cells Causes the Late Onset of Acute Hepatitis C
2011 StandoutNobel
Recent advances in the molecular biology of hepatitis C virus
2001
Structure and Redox Properties of the Haem Centre in the C357M Mutant of Cytochrome P450cam
2005
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Review of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma
2002
Preparation of Large Monodisperse Vesicles
2009 StandoutNobel
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
Nanomedicine
2006
Structural and mechanistic insights into hepatitis C viral translation initiation
2006 StandoutNobel
Three-dimensional structure by cryo-electron microscopy of YvcC, an homodimeric ATP-binding cassette transporter from Bacillus subtilis
2002
Organocatalytic Asymmetric Hydrolysis of Epoxides
2014 StandoutNobel
TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action
2016 StandoutNatureNobel
Integrated Nanoparticle–Biomolecule Hybrid Systems: Synthesis, Properties, and Applications
2004 Standout
Poly(ethylene glycol) in Drug Delivery: Pros and Cons as Well as Potential Alternatives
2010 Standout
Microtubules as a target for anticancer drugs
2004 Standout
SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 Nonresponders
2007
Revealing the world of RNA interference
2004 StandoutNatureNobel
Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase
2005 StandoutNatureNobel
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
2001 Standout
Organic Switches for Surfaces and Devices
2012 StandoutNobel
Reconstitution of Membrane Proteins in Phospholipid Bilayer Nanodiscs
2009
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
2011 Standout
The way forward in HCV treatment — finding the right path
2007 StandoutNobel
New therapeutic strategies for hepatitis C
2002 StandoutNobel
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Hepatitis C virus kinetics and host responses associated with disease and outcome of infection in chimpanzees
2004 StandoutNobel
Drug–drug interactions with systemic antifungals in clinical practice
2007
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
A Randomized, Double–Blind Trial Comparing Pegylated Interferon Alfa–2B to Interferon Alfa–2B As Initial Treatment for Chronic Hepatitis C
2001
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Human Pharmacogenomic Variations and Their Implications for Antifungal Efficacy
2006
One-Component Multifunctional Sequence-Defined Ionizable Amphiphilic Janus Dendrimer Delivery Systems for mRNA
2021 StandoutNobel
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
2002 Standout
DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection
2001
Conazoles
2010
Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C
2005 StandoutNobel
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
2004 StandoutNobel
Interferon-α as an immunotherapeutic protein
2002
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Mammalian ABC Transporters in Health and Disease
2002
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
2002 StandoutNobel
Drug Delivery Systems: Entering the Mainstream
2004 StandoutScience
Interference of hepatitis C virus RNA replication by short interfering RNAs
2003
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Viral persistence, liver disease, and host response in a hepatitis C–like virus rat model
2017 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Structural insight into TRPV5 channel function and modulation
2019 StandoutNobel
Future Therapies for Hepatitis C
2006
Dendrimers Designed for Functions: From Physical, Photophysical, and Supramolecular Properties to Applications in Sensing, Catalysis, Molecular Electronics, Photonics, and Nanomedicine
2010 Standout
Protein-Protein Interactions between Hepatitis C Virus Nonstructural Proteins
2003
Novel Therapies for Hepatitis C: Insights from the Structure of the Virus
2011
Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption
2004 StandoutScience
Cytochrome P450 and Chemical Toxicology
2007
Interferon-alpha as an immunotherapeutic protein.
2002
Structural Adaptability Facilitates Histidine Heme Ligation in a Cytochrome P450
2015 StandoutNobel
Works of Robert P. Clement being referenced
Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine
1996
A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis C
2000
Cytochrome P450 Enzymes and Drug Metabolism—Basic Concepts and Methods of Assessment
1999
Cholesterol Interaction with the Daunorubicin Binding Site of P-Glycoprotein
2000
Active Transport of Fluorescent P-Glycoprotein Substrates: Evaluation as Markers and Interaction with Inhibitors
2001
In vitro characterization of the inhibition profile of loratadine, desloratadine, and 3-OH-desloratadine for five human cytochrome P-450 enzymes.
2001
Interaction of Common Azole Antifungals with P Glycoprotein
2002
Mechanism-based inactivation of CYP2D6 by 5-fluoro-2-[4-[(2-phenyl-1H-imidazol-5-yl)methyl]-1-piperazinyl]pyrimidine.
2001
Bioavailability and Metabolism of Mometasone Furoate following Administration by Metered‐Dose and Dry‐Powder Inhalers in Healthy Human Volunteers
2000